Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-23

Clinical Trial Update: Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen [Phase 4]

View source ↗

Summary

Phase 4 surveillance trial updating on a shortened IV ibuprofen infusion time; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (intravenous, shortened infusion time) (ibuprofen)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Pain, Fever | Phase 4 | Status: COMPLETED | Results posted: 2014-06-23